BeStock  

Ironwood Pharmaceuticals IRWD

US equityMarket cap rank #3323Drug Manufacturers - Specialty & Generic
$4.70 −$0.01 (-0.21%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $4.60 -2.13%
Open$4.66
Prev close$4.71
Day range$4.65 – $4.87
Volume3.02M
Market cap$778.09M
P/E (TTM)5.2
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership95.8%-4.36 pts vs. prior quarter
Institutions holding275+14 vs. prior quarter
Insider trades (recent)28 buys / 22 sellsNet buying
Short interest8.99% of floatDays to cover 9.8 · as of 30 Oct 2026
Short-sale volume share24.7%5-day average of daily volume

Short-sale volume as % of daily volume

9%18%28%38%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$3.75M (4 inflow days, 16 outflow days).

Net flow by order size, last 20 sessions

−$1.9MSuper−$1.9MBig−$2.4MMid−$2.3MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 34.0% of shares outstanding.

Largest holders

  • BlackRock11.16%
  • Armistice Capital LLC8.42%
  • Sarissa Capital Management LP5.55%
  • Renaissance Technologies Corp.4.86%
  • State Street Global Advisors4.06%
  • Vanguard Capital Management, LLC4.01%
  • AQR Capital Management3.80%
  • Bank of America Corporation3.15%

By investor type

  • Mutual Fund57.24%
  • Hedge Fund29.24%
  • Public Company6.78%
  • Individual/Insider3.23%
  • Private Company0.90%
  • Government Pension Fund0.80%
  • Bank/Investment Bank0.29%
  • Family Office/Trust0.25%

Reported short interest has fallen from 10.93% to 8.99% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
O'Shaughnessy Asset Management, LLC Mutual Fund 2026/Q3 +937,699 0.8%
BlackRock Mutual Fund 2026/Q3 +686,889 11.2%
First Trust Advisors L.P. Mutual Fund 2026/Q3 +659,731 0.4%
Ritholtz Wealth Management Mutual Fund 2026/Q3 +470,997 0.5%
FMR Mutual Fund 2026/Q3 +342,619 0.8%
Principal Global Investors, LLC Mutual Fund 2026/Q3 +306,858 0.2%
LPL Financial LLC Mutual Fund 2026/Q3 +280,240 0.2%
Franklin Resources Mutual Fund 2026/Q3 +264,298 0.8%
CWA Asset Management Group, LLC Mutual Fund 2026/Q3 +208,277 0.3%
Legato Capital Management, LLC Mutual Fund 2026/Q3 +180,409 0.1%
Focus Partners Wealth, LLC Mutual Fund 2026/Q3 +167,692 0.1%
Virtus Investment Advisers, LLC Mutual Fund 2026/Q3 +143,181 0.3%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +313,518 0.2%
BlackRock Mutual Fund 2026/Q3 +4,425,627 10.8%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +1,807,459 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
15 Nov 2026 Tammi Gaskins Senior Vice President & Chief Commercial Officer Intent to Sell (Form 144) -6,666 $4.85 –
23 Sep 2026 Michael Shetzline Former Chief Medical Officer, Senior VP and Head of Research & Drug Development Intent to Sell (Form 144) -83,306 $4.53 –
14 Sep 2026 Alexander Denner Independent Director Other Acquisition +3,694 – 327,549
19 Jul 2026 Jeffrey Silber Chief Medical Officer, Head of Research & Drug Development Other Acquisition +137,036 – 137,036
6 Jul 2026 Ronald Silver Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer Automatic Disposition -127,890 $4.52 2,235
15 Jun 2026 Jay Shepard Independent Director Other Acquisition +63,481 – 235,036
15 Jun 2026 Mark Currie Independent Director Other Acquisition +63,481 – 676,900
15 Jun 2026 Catherine Moukheibir Independent Director Other Acquisition +63,481 – 181,425
15 Jun 2026 Julie McHugh Independent Chairperson Other Acquisition +63,481 – 250,749
15 Jun 2026 Julie McHugh Independent Chairperson Automatic Disposition -21,571 $3.73 250,749
15 Jun 2026 Marla Kessler Independent Director Other Acquisition +63,481 – 229,364
15 Jun 2026 Jon Duane Independent Director Other Acquisition +63,481 – 253,820
15 Jun 2026 Alexander Denner Independent Director Other Acquisition +67,546 – 323,855
18 May 2026 Ronald Silver Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer Other Acquisition +25,000 – 311,445
16 Mar 2026 Sarissa Capital Management LP Open Market Disposition -6,730,800 $3.31 9,188,635
12 Mar 2026 Alexander Denner Independent Director Other Acquisition +4,451 – 256,309
9 Mar 2026 Thomas McCourt Chief Executive Officer Other Acquisition +409,836 – 1,038,128
9 Mar 2026 Michael Shetzline Former Chief Medical Officer, Senior VP and Head of Research & Drug Development Other Acquisition +136,612 – 281,293
9 Mar 2026 Ronald Silver Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer Other Acquisition +163,934 – 286,445
9 Mar 2026 John Minardo Chief Legal Officer Other Acquisition +136,612 – 271,868

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 14,860,120 9.0% 9.8
15 Oct 2026 15,887,553 9.6% 8.0
30 Sep 2026 15,567,942 9.4% 6.2
15 Sep 2026 18,728,986 11.3% 13.1
31 Aug 2026 17,654,677 10.7% 11.9
14 Aug 2026 18,066,382 10.9% 6.4

Discussion

No comments yet — be the first to weigh in on IRWD.

Sign in to join the discussion.

Scroll to Top